Albireo Pharma, Inc.

ALBO · NASDAQ
Analyze with AI
9/30/2022
6/30/2022
3/31/2022
12/31/2021
Assets
Cash & Equivalents$222,476$180,971$216,655$248,107
Short-Term Investments$0$0$0$0
Receivables$2,029$1,849$1,275$3,272
Inventory$3,149$2,096$1,821$194
Other Curr. Assets$2,666$2,666$2,490$12,096
Total Curr. Assets$238,836$195,752$228,727$268,930
Property Plant & Equip (Net)$1,303$1,388$837$668
Goodwill$17,260$17,260$17,260$17,260
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$63,823$14,614$14,437$15,193
Total NC Assets$82,386$33,262$32,534$33,121
Other Assets$0$0$0$0
Total Assets$321,222$229,014$261,261$302,051
Liabilities
Payables$6,950$5,394$6,369$6,516
Short-Term Debt$0$10,158$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$30,869$28,039$25,138$38,831
Total Curr. Liab.$37,819$43,591$31,507$45,347
LT Debt$0$0$10,080$10,004
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$183,332$71,746$71,488$71,092
Total NC Liab.$183,332$71,746$81,568$81,096
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$221,151$115,337$113,075$126,443
Equity
Pref Stock$0$0$0$0
Common Stock$207$196$195$193
Retained Earnings-$421,033-$383,233-$343,284-$300,850
AOCI$8,212$8,252$8,229$1,105
Other Equity$512,685$488,462$483,046$475,160
Total Equity$100,071$113,677$148,186$175,608
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$321,222$229,014$261,261$302,051
Net Debt-$222,476-$170,813-$206,575-$238,103